ACADIA Pharmaceuticals Inc.
ACAD | NASDAQ
$26.39
-$0.90 (-3.30%)
At close: Sep 21, 2026, 4:00 PM ET
$26.39
$0 (+0.02%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $4.67B
Enterprise Value $3.64B
Beta 0.86
Average Volume 1.63M
Shares Outstanding (Diluted) 172.85M
Shares Change YoY 2.47%
Institutional Ownership 96.66%
Exchange NASDAQ
ISIN US0042251084
Price Performance
Price Change 1M -10.5%
Price Change 3M 16.8%
Price Change 6M 19.9%
Price Change YTD 0.4%
Price Change 1Y 7.6%
Price Change 3Y 12.0%
Price Change 5Y 55.8%
1M CAGR (ann.) -4.1%
1Y CAGR (ann.) 12.8%
5Y CAGR (ann.) 11.1%
All-Time CAGR 5.6%
Valuation
PE Ratio 11.89
Forward PE 28.59
PEG Ratio 0.18
Forward PEG 0.25
PS Ratio 3.97
Forward PS 3.20
PB Ratio 3.46
P/FCF Ratio 25.92
P/Adj. FCF Ratio 39.34
P/OCF Ratio 23.35
EV/Sales 3.19
EV/EBIT 34.94
EV/EBITDA 31.32
EV/FCF 20.86
Earnings Yield 8.4%
FCF Yield 3.9%
Adj. FCF Yield 2.5%
Financial Health
Net Cash $956.47M
Total Debt $73.85M
Cash & Short-Term Investments $956.47M
Total Assets $1.74B
Current Ratio 3.39
Quick Ratio 3.30
Debt / Equity Ratio 0.06
Debt / EBITDA 0.64
Debt / FCF 0.42
OCF / Debt 2.63
Interest Coverage 0.00
Altman Z-Score 6.44
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 91.1%
Operating Profit Margin 7.6%
EBITDA Margin 10.2%
Net Profit Margin 33.4%
FCF Margin 15.3%
Adj. FCF Margin 10.1%
SBC / Revenue 5.2%
SBC Impact (per share) -34.1%
Returns
Return on Assets 21.8%
Return on Equity 32.4%
Return on Invested Capital 6.2%
Return on Capital Employed 6.3%
Return on Tangible Assets 23.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 27.4%
Revenue CAGR 5Y 19.7%
Revenue CAGR 10Y 143.3%
EPS CAGR 3Y 82.0%
EPS CAGR 5Y 254.2%
EPS CAGR 10Y 61.3%
FCF CAGR 3Y 31.9%
FCF CAGR 5Y 149.2%
FCF CAGR 10Y 79.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 37
EPS Growth Next 3Y -4.2%
Revenue Growth Next 3Y 15.3%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.21
EPS Growth Est (next Q) -50.0%
Revenue Est (next Q) $332.31M
Revenue Growth Est (next Q) 19.3%
Fair Value Estimates
Graham Number $19.50
Graham Upside -26.1%
Lynch Fair Value $55.50
Lynch Upside 110.3%
Price Target $33.83
Price Target Upside 28.2%
Cash Flow
Operating Cash Flow $194.3M
Free Cash Flow $174.39M
Adj. Free Cash Flow $114.88M
FCF Per Share $1.02
OCF Per Share $1.13
OCF/S Ratio 17.1%
Income Statement
Revenue $1.14B
Gross Profit $1.04B
Operating Income $86.37M
EBITDA $116.12M
Net Income $380.48M
EPS (Diluted) $2.22
Revenue / Employee $1.43M
Profit / Employee $477.4K
Employees 797
Add to Watchlist
Select watchlists to add or remove ACAD